Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation-Reference-Cited by-同舟云学术

Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation

Published:2024-04 Issue:6 Volume:46 Page:538-543
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Ma Li¹²,Zhang He²³,Duan Guangxin²³,Luo Yun²³,Zhang Xi²³,Lu Zhengjuan²³,Chen Zhibin²³,Yu Linjie²³,Zhang Tingzheng²³,Xu Yun²³,Li Jingwei¹²³

Affiliation:

1. Department of Neurology, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China

2. Jiangsu Province Stroke Center for Diagnosis and Therapy, Nanjing, China

3. Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, China

Funder

there is no funding associated

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2024.2337518

Reference33 articles.

1. Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China

2. Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis

3. Treatment of basilar artery stenosis with an Apollo balloon-expandable stent: a single-centre experience with 61 consecutive cases

4. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial

5. Clinical and angiographic outcomes after stent-assisted coiling of cerebral aneurysms with Enterprise and Neuroform stents: a comparative analysis of the literature